These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Clinical significance of respiratory infection caused by Branhamella catarrhalis with special reference to beta-lactamase producing strains. Nagatake T Tohoku J Exp Med; 1985 Sep; 147(1):1-13. PubMed ID: 3000026 [TBL] [Abstract][Full Text] [Related]
44. The PROTEKT surveillance study: antimicrobial susceptibility of Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections. Hoban D; Felmingham D J Antimicrob Chemother; 2002 Sep; 50 Suppl S1():49-59. PubMed ID: 12239228 [TBL] [Abstract][Full Text] [Related]
45. Moraxella catarrhalis: a review of an important human mucosal pathogen. Karalus R; Campagnari A Microbes Infect; 2000 Apr; 2(5):547-59. PubMed ID: 10865200 [TBL] [Abstract][Full Text] [Related]
46. Clinical interpretation of beta-lactamase-producing strains of Branhamella catarrhalis in sputum Gram's stain and culture. Robinson A; Johnson PC; Griffith SB Am J Clin Pathol; 1987 Apr; 87(4):498-503. PubMed ID: 3548321 [TBL] [Abstract][Full Text] [Related]